Clinical pharmacokinetics of neuromuscular relaxants in pregnancy

Clinical Pharmacokinetics

Volumn 34, Issue 6, 1998, Pages 483-496

  Guay, Joanne ^a   Grenier, Yvan ^a   Varin, France ^b  

^a MAISONNEUVE ROSEMONT HOSPITAL   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ATRACURIUM; CHOLINESTERASE; HISTAMINE H2 RECEPTOR ANTAGONIST; MAGNESIUM SULFATE; METOCLOPRAMIDE; MUSCLE RELAXANT AGENT; PANCURONIUM; SUXAMETHONIUM; VECURONIUM;

BLOOD VOLUME; CESAREAN SECTION; CHOLINESTERASE BLOOD LEVEL; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG ELIMINATION; FASCICULATION; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; MOLECULAR WEIGHT; MYALGIA; PLASMA VOLUME; PREECLAMPSIA; PREGNANCY; PRIORITY JOURNAL; RESPIRATORY DISTRESS; REVIEW; STEADY STATE; WEIGHT GAIN;

ABSORPTION; DRUG INTERACTIONS; FEMALE; HALF-LIFE; HUMANS; INFANT, NEWBORN; NEUROMUSCULAR DEPOLARIZING AGENTS; PREGNANCY;

EID: 0031844409     PISSN: 03125963     EISSN: None     Source Type: Journal    
DOI: 10.2165/00003088-199834060-00004     Document Type: Review

References (86)

1. Cheek TG, Gutsche BB. Maternal physiologic alterations during pregnancy. In: Shnider SM, Levinson G, editors. Anesthesia for obstetrics. 3rd ed. Baltimore: Williams and Wilkins, 1993: 3-17
2. Reynolds F, Knott C. Pharmacokineties in pregnancy and placental drug transfer. Oxford Rev Reprod Biol 1989; 11: 389-49
3. Notarianni LJ. Plasma protein binding of drugs in pregnancy and in neonates. Clin Pharmacokinet 1990; 18: 20-36
4. Knott C, Reynolds F. Therapeutic drug monitoring in pregnancy: rationale and current status. Clin Pharmacokinet 1990; 19 (6): 425-33
5. Guay J, Beaudry B, Lortie L, et al. Pharmacokinetics of atracurium in pregnant women. Clin Drug Invest 1996; 11 (3): 167-73
6. Duvaldestin P, Demetriou M, Henzel D, et al. The placental transfer of pancuronium and its pharmacokinetics during cesarean section. Acta Anaesth Scand 1978; 22: 327-33
7. Dailey PA, Fisher DM, Shnider SM, et al. Pharmacokinetics, placental transfer, and neonatal effects of vecuronium and pancuronium administered during cesarean section. Anesthesiology 1984; 60 (6): 569-74
8. Cronelly R, Fisher DM, Miller RD, et al. Pharmacokinetics and pharmacodynamics of vecuronium (ORG NC45) and pancuronium in anesthetized humans. Anesthesiology 1983; 58 (5): 405-8
9. Merrett RA, Thompson CW, Webb FW. In vitro degradation of atracurium in human plasma. Br J Anaesth 1983; 55: 61-6
10. Stiller RL, Cook DR, Chakravorti S. In vitro degradation of atracurium in human plasma. Br J Anaesth 1985; 57: 1085-8
11. Ward S, Boheimer N, Weatherley BC, et al. Pharmacokinetics of atracurium and its metabolites in patients with normal renal function, and in patients in renal failure. Br J Anaesth 1987; 59: 697-706
12. Tsui D, Graham GG, Torda TA. The pharmacokinetics of atracurium isomers in vitro and in humans. Anesthesiology 1987; 67: 722-8
13. Fisher DM, Canfell PC, Fahey MR, et al. Elimination of atracurium in humans: contribution of Hofmann elimination and ester hydrolysis versus organ-based elimination. Anesthesiology 1986; 65: 6-12
14. Khuenl-Brady KS, Koller J, Mair P, et al. Comparison of vecuronium- and atracurium-induced neuromuscular blockade in postpartum and nonpregnant patients. Anesth Analg 1991; 72: 110-3
15. Agoston S, Vandenbrom RHG, Wierda JMKH. Clinical pharmacokinetics of neuromuscular blocking drugs. Clin Pharmacokinet 1992; 22 (2): 94-115
16. Patel R, Katz R, Martinez V, et al. Effects of mivacurium-induced neuromuscular blockade in the postpartum patients [abstract]. Anesthesiology 1993; 79: A967
17. Gin T, Derrick JL, Chan MTV, et al. Postpartum patients have slightly prolonged neuromuscular block after mivacurium. Anesth Analg 1998; 86: 82-5
18. Camp CE, Tessem J, Adenwala J, et al. Vecuronium and prolonged neuromuscular blockade in postpartum patients. Anesthesiology 1987; 67: 1006-8
19. Hawkins JL, Adenwala J, Camp C, et al. The effect of H2-receptor antagonist premedication on the duration of vecuronium-induced neuromuscular blockade in postpartum patients. Anesthesiology 1989; 71 (2): 175-7
20. Hawkins JL, Johnson TD, Kubicek MA, et al. Vecuronium for rapid-sequence intubation for cesarean section. Anesth Analg 1990; 71: 185-90
21. Baraka A, Jabbour S, Tabboush Z, et al. Onset of vecuronium neuromuscular block is more rapid in patients undergoing caesarean section. Can J Anaesth 1992; 39 (2): 135-8
22. Patel R, Moran V, Katz R, et al. The onset and duration of action of rocuronium is not prolonged during the postpartum period [abstract]. Anesthesiology 1996; 85: A826
23. Pühringer FK, Sparr HJ, Mitterschiffthaler G, et al. Extended duration of action of rocuronium in postpartum patients. Anesth Analg 1997; 84: 352-4
24. Bencini AF, Scaf AHJ, Sohn YJ, et al. Hepatobiliary disposition of vecuronium bromide in man. Br J Anaesth 1986; 58: 988-95
25. Bencini AF, Scaf AHJ, Sohn YJ, et al. Disposition and urinary excretion of vecuronium bromide in anesthetized patients with normal renal function or renal failure. Anesth Analg 1986; 65: 245-51
26. Dam M, Christiansen J, Munck O, et al. Antiepileptic drugs: metabolism in pregnancy. Clin Pharmacokinet 1979; 4: 53-62
27. Cameron M, Donati F, Varin F. In vitro plasma protein binding of neuromuscular blocking agents indifferent subpopulations of patients. Anesth Analg 1995; 81: 1019-25
28. Wood M, Wood AJJ. Changes in plasma drug binding and α-1-acid glycoprotein in mother and newborn infant. Clin Pharmacol Ther 1981; 29 (4): 522-6
29. Abouleish E, Abboud T, Lechevalier T, et al. Rocuronium (Org 9426) for caesarean section. Br J Anaesth 1994; 73: 336-41
30. Magorian T, Flannery KB, Miller RD. Comparison of rocuronium, succinylcholine and vecuronium for rapid-sequence induction of anesthesia in adult patients. Anesthesiology 1993; 79: 913-8
31. Pacifi GM, Nottoli R. Placental transfer of drugs administered to the mother. Clin Pharmacokinet 1995; 28 (3): 235-69
32. Flynn PJ, Frank M, Hughes R. Use of atracurium in caesarean section. Br J Anaesth 1984; 56: 599-605
33. Shearer ES, Fahy LT, O'Sullivan EP, et al. Transplacental distribution of atracurium, laudanosine and monoquaternary alcohol during elective caesarean section. Br J Anaesth 1991; 66: 551-6
34. Perreault C, Guay J, Gaudreault P, et al. Residual curarization of the neonate after caesarean section. Can J Anaesth 1991; 38 (5): 587-91
35. Bertrand JC, Duvaldestin P, Henkel D, et al. Quantitative assessment of placental transfer of fazadinium in obstetric anaesthesia. Acta Anaesth Scand 1980; 24: 135-7
36. Demetriou M, Depoix JP, Diakite B, et al. Placental transfer of Org NC 45 in women undergoing caesarean section. Br J Anaesth 1982; 54: 643-5
37. Booth PN, Watson MJ, McLeod K. Pancuronium and the placental barrier. Anaesthesia 1977; 32: 320-3
38. Abouleish E, Wingard LB, de la Vega S, et al. Pancuronium in caesarean section and its placental transfer. Br J Anaesth 1980; 52: 531-6
39. Lee C, Kwan WF, Chen BJ, et al. Neuromuscular blocking effect and placental gradient of pipecuronium bromide in elective caesarean section. Proceedings of the National Science Council, ROC: part B. Life Sci 1992; 16 (3): 119-24
40. Duvaldestin P, Henzel D. Binding of tubocurarine, fazadinium, pancuronium and ORG NC 45 to serum proteins in normal man and in patients with cirrhosis. Br J Anaesth 1982; 54: 513-6
41. Wood M, Stone WJ, Wood AJJ. Plasma binding of pancuronium: effects of age, sex and disease. Anesth Analg 1983; 62: 29-32
42. Fisher DM, Canfell PC, Spellman MJ, et al. Pharmacokinetics and pharmacodynamics of atracurium in infants and children. Anesthesiology 1990; 73: 33-7
43. Amiel-Tison C, Barrier G, Shnider SM, et al. A new neurologic and adaptive capacity scoring system for evaluating obstetric medications in full-term newborns. Anesthesiology 1982; 56: 340-50
44. Guay J, Gaudreault P, Boulanger A, et al. Lidocaine hydrochloride and lidocaine hydrocarbonate: transplacental passage and neonatal effects. Acta Anesthesiol Scand 1992; 36: 722-7
45. Seeds JW, Corke BC, Spielman FJ. Prevention of fetal movement during invasive procedures with pancuronuim bromide. Am J Obstet Gynecol 1986; 155: 818-9
46. Leveque C, Murat I, Toubas F, et al. Fetal neuromuscular blockade with vecuronium bromide: studies during intravascular intrauterine transfusion in isoimmunized pregnancies. Anesthesiology 1992; 76: 642-4
47. Jago RH. Arthrogryposis following treatment of maternal tetanus with muscle relaxants. Arch Dis Child 1970; 45: 277-9
48. Hawkins JL, Koonin LM, Palmer SK, et al. Anesthesia-related deaths during obstetric delivery in the United States, 1979-1990. Anesthesiology 1997; 86: 277-84
49. Wright PM, Caldwell JE, Miller RD. Onset and duration of rocuronium and succinylcholine at the adductor pollicis and laryngeal adductor muscles in anesthetized humans. Anesthesiology 1995; 81 (5): 1110-5
50. Baraka A, Haroun S, Bassili M, et al. Response of the newborn to succinylcholine injection in homozygotic atypical mothers. Anesthesiology 1975; 43: 115-6
51. Carnie JC, Street MK, Kumar B. Emergency intubation of the trachea facilitated by suxamethonium. Br J Anaesth 1986; 58. 498-501
52. Peek AW. Relative importance of the enzymatic hydrolysis of suxamethonium in plasma and tissues: studies in rhesus monkeys. Br J Pharmacol 1971; 45: 64-70
53. Savarese JJ, Miller RD, Lien CA, et al. Pharmacology of muscle relaxants and their antagonists. In: Miller RD, editor. Anesthesia. 4th ed. New York: Churchill Livingstone, 1994: 417-88
54. Zeller EA, Burkhauser H, Wattenwyl HV, et al. Geschlechtsfunktion und Serum-Cholinesterase des Menschen. 3. Mitteilung über Beziehhungen zwischen Sexualhormonen und Fermenten. Helvetica Chim Acta 1941; 24: 962-8
55. Shnider SM. Serum cholinesterase activity during pregnancy, labor and puerperium. Anesthesiology 1965; 26: 335-9
56. Evans RT, Wroe JM. Plasma cholinesterase changes during pregnancy. Anaesthesia 1980; 35: 651-4
57. Ravindran RS, Cummins DF, Pantazis KL, et al. Unusual aspects of low levels of pseudocholinesterase in a pregnant patient. Anesth Analg 1982; 61: 953-5
58. Friedman MM, Lapan B. Variations of enzyme activities during normal pregnancy. Am J Obstet Gynecol 1950; 60: 1343-7
59. Pritchard JA. Plasma cholinesterase activity in normal pregnancy and eclamptogenic toxemias. Am J Obstet Gynecol 1955; 70: 1083-6
60. Tourtelotte WW, Odell LD. Plasma acetylcholinesterase activity. Am J Obstet Gynecol 1950; 60: 1343-7
61. Blitt CD, Petty WC, Alberternst EE, et al. Correlation of plasma cholinesterase activity and duration of action of succinylcholine during pregnancy. Anesth Analg 1977; 56: 78-83
62. Leighton BL, Cheek TG, Gross JB, et al. Succinylcholine pharmacodynamics in peripartum patients. Anesthesiology 1986; 64: 202-5
63. Hoshi K, Hashimoto Y, Matsukawa S. Pharmacokinetics of succinylcholine in man. Tohoku J Exp Med 1993; 170: 245-50
64. Wildsmith JAW. Serum pseudocholinesterase, pregnancy and suxamethonium. Anaesthesia 1972; 27: 90-1
65. Weissman DB, Ehrenwerth J. Prolonged neuromuscular blockade in a parturient associated with succinylcholine. Anesth Analg 1983; 62: 444-6
66. Donati F, Bevan DR. Succinylcholine in obstetrics [letter]. Anesth Analg 1983; 62: 1051-2
67. Cherala S, Eddie D, Halpern M, et al. Priming with vecuronium in obstetrics [letter]. Anaesthesia 1987; 42: 1021
68. Crawford JS. Suxamethonium muscle pains and pregnancy. Br J Anaesth 1971; 43: 677-80
69. Datta S, Crocker JS, Alper MH. Muscle pain following administration of suxamethonium to pregnant and non-pregnant patients undergoing laparoscopic tubal ligation. Br J Anaesth 1977; 49: 625-8
70. Thind GS, Bryson THL. Single dose suxamethonium and muscle pain in pregnancy. Br J Anaesth 1983; 55: 743-5
71. Cook WP, Schultetus RR, Caton D. A comparison of d-tubocurarine pretreatment and no pretreatment in obstetric patients. Anesth Analg 1987; 66: 756-60
72. Felton DJC, Goddard BA. The effect of suxamethonium chloride on uterine activity. Lancet 1966; 1 (442): 852-4
73. Luppa JB, Smith GA, Colella JJ, et al. Succinylcholine effect on human myometrical activity. Obst Gyn 1971; 37: 591-5
74. Healy TEJ. Suxamethonium and intra-uterine picture. Br J Anaesth 1971; 43: 1156-8
75. Kvisselgaard N, Moya F. Investigation of placental thresholds to succinylcholine. Anesthesiology 1961; 22: 7-10
76. Owens WD, Zeitlin GL. Hypoventilation in a newborn following administration of succinylcholine to the mother: a case report. Anesth Analg 1975; 54: 38-40
77. Hoefnagel D, Harris A, Kim TH. Transient respiratory depression of the newborn. Am J Dis Child 1979; 133: 825-6
78. Dupuis JY, Martin R, Tetrault JP. Atracurium and vecuronium interaction with gentamycin and tobramycin. Can J Anaesth 1989; 36 (4): 407-11
79. Giesecke Jr AH, Morris RE, Dalton MD, et al. Of magnesium, muscle relaxants, toxemic parturients, and cats. Anesth Analg 1968; 47 (6): 689-95
80. Ahn EK, Bai SJ, Cho BJ, et al. The infusion rate of mivacurium and its spontaneous neuromuscular recovery in magnesium treated participants. Anesth Analg 1998; 86: 523-6
81. Baraka A, Yazigi A. Neuromuscular interaction of magnesium with succinylcholine-vecuronium sequence in the eclamptic parturient. Anesthesiology 1987; 67: 806-8
82. Gaiser RR, Seem EH. Use of rocuronium in a pregnant patient with an open eye injury, receiving magnesium medication, for preterm labour. Br J Anaesth 1996; 77: 669-71
83. Salib Y, Donati F. Potentiation of pancuronium and vecuronium neuromuscular blockade by intravenous salbutamol. Can J Anaesth 1993; 40 (1): 50-3
84. James MFM, Cork RC, Dennett JE. Succinylcholine pretreatment with magnesium sulfate. Anesth Analg 1986; 65: 373-6
85. 2 antagonists on duration of action of suxamethonium in the parturient. Anaesthesia 1989; 44: 591-3
86. Turner DR, Kao YJ, Bivona C. Neuromuscular block by suxamethoniuin following treatment with histamine type 2 antagonists or metoclopramide. Br J Anaesth 1989; 63: 348-50